nisoldipine has been researched along with Genetic Diseases in 1 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Splawski, I | 1 |
Timothy, KW | 1 |
Sharpe, LM | 1 |
Decher, N | 1 |
Kumar, P | 1 |
Bloise, R | 1 |
Napolitano, C | 1 |
Schwartz, PJ | 1 |
Joseph, RM | 1 |
Condouris, K | 1 |
Tager-Flusberg, H | 1 |
Priori, SG | 1 |
Sanguinetti, MC | 1 |
Keating, MT | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives[NCT04832126] | 100 participants (Anticipated) | Observational | 2018-01-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for nisoldipine and Genetic Diseases
Article | Year |
---|---|
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
Topics: Abnormalities, Multiple; Action Potentials; Animals; Arrhythmias, Cardiac; Autistic Disorder; Brain; | 2004 |